From: Prioritising Cochrane reviews to be updated with health equity focus
Effective Coverage Indicators from the Universal Health Coverage Measurement Framework |
---|
Tuberculosis treatment |
Acute lymphoid leukaemia treatment |
Breast cancer treatment |
Cervical cancer treatment |
Uterine cancer treatment |
Colon and rectum cancer treatment |
Ischaemic heart disease treatment |
Stroke treatment |
Diabetes treatment |
Chronic kidney disease treatment |
Chronic obstructive pulmonary disease treatment |
Asthma treatment |
Epilepsy treatment |
Diarrhoea treatment |
Lower respiratory infections treatment |
Appendicitis treatment |
Paralytic ileus and intestinal obstruction treatment |
Antiretroviral therapy coverage |
Met need for family planning with modern contraception |
Measles-containing-vaccine coverage, 1 dose |
Diphtheria-tetanus-pertussis vaccine coverage, 3 doses |
Additional Conditions |
Malaria |
Buruli ulcer |
Chagas disease |
Dengue and Chikungunya |
Dracunculiasis (guinea-worm disease) |
Echinococcosis |
Foodborne trematodiases |
Human African trypanosomiasis (sleeping sickness) |
Leishmaniasis |
Leprosy (Hansen’s disease) |
Lymphatic filariasis |
Mycetoma, chromoblastomycosis and other deep mycoses |
Onchocerciasis (river blindness) |
Rabies |
Scabies and other ectoparasites |
Schistosomiasis |
Soil-transmitted helminthiases |
Snakebite envenoming |
Taeniasis/Cysticercosis |
Trachoma |
Yaws (Endemic treponematoses) |